| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.1M | +2481.5% |
| Cost of Revenue | $616K | +624.7% |
| R&D Expense | $84.5M | +43.5% |
| SG&A Expense | $143.1M | +25.5% |
| Operating Income | -$197.1M | -14.8% |
| Income Tax | $0 | — |
| Net Income | -$200.4M | -13.1% |
| EPS (Basic) | -$0.63 | +21.3% |
| EPS (Diluted) | -$0.63 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.7M | +196.7% |
| Short-term Investments | $171.3M | +16.1% |
| Accounts Receivable | $3.5M | +243.9% |
| Inventory | $231K | -39.4% |
| Current Assets | $246.2M | +39.4% |
| Total Assets | $298.4M | +30.1% |
| Current Liabilities | $45.2M | +43.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$178.8M | -10.4% |
| Capital Expenditures | $1.0M | +119.4% |
| Investing Cash Flow | -$15.4M | +69.2% |
| Financing Cash Flow | $238.3M | +26.8% |
| Free Cash Flow | -$179.8M | -10.7% |
| +21.3% |
| Long-term Debt |
| $100.3M |
| +0.8% |
| Total Liabilities | $152.5M | +11.8% |
| Stockholders' Equity | $145.9M | +56.8% |